Does metformin increase the serum total homocysteine level in non- insulin-dependent diabetes mellitus?

Journal of Internal Medicine

Volumn 242, Issue 5, 1997, Pages 389-394

  Hoogeveen, E K ^a,d   Kostense, P J ^a,c   Jakobs, C ^c   Bouter, L M ^a,c   Heine, R J ^a,b   Stehouwer, C D A ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b University Hospital   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Atherosclerosis; Homocysteine; Metformin; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; HOMOCYSTEINE; METFORMIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0030859860     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1997.00231.x     Document Type: Article

References (37)

1. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 1974; 23: 105-11.
2. Meinert CL, Knatterud GL, Prout TE, Klimt CR. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 1970; 19 (Suppl. 2): 789-830.
3. University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of phenformin therapy. Diabetes 1975; 24 (Suppl. 1): 65-184.
4. Genuth S. Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus. Ann Intern Med 1996; 124: 104-9.
5. Turner R, Cull C, Holman R. United Kingdom prospective diabetes study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 1996; 124: 136-45.
6. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995; 274: 1049-57.
7. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992; 268: 877-81.
8. Araki A, Sako Y, Ito H. Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment. Atherosclerosis 1993; 103: 149-57.
9. DeFronzo RA, Goodman AM and the Multicenter Metformin Study Group. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333: 541-9.
10. Berchtold P, Bolli P, Arbenz U, Keiser G. Intestinale Absorptionsstörung infolge Metforminbehandlung. Diabetologia 1969; 5: 405-12.
11. Naurath HJ, Joosten E, Riezler R, Stabler SP, Allen RH, Lindenbaum J. Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet 1995; 346: 85-9.
12. Shaw S, Jayatilleke E, Bauman W, Herbert V. Mechanism of B12 malabsorption and depletion due to metformin discovered by using serial serum holo-transcobalamin II (holo TCII) (B12 on TCII) as a surrogate for serial Schilling tests. Blood 1993; 82 (Suppl. 1): 432A.
13. Adams JF, Clark JS, Ireland JT, Kesson CM, Watson WS. Malabsorption of vitamin B12 and intrinsic factor secretion during biguanide therapy. Diabetologia 1983; 24: 16-18.
14. Joosten E, van den Berg A, Riezler R, Naurath HJ, Lindenbaum J, Stabler SP et al. Metabolic evidence that deficiencies of vitamin B-12 (cobalamin). folate and vitamin B-6 occur commonly in elderly people. Am J Clin Nutr 1993; 58: 468-76.
15. Pennypacker LC, Allen RH, Kelly JP, Matthews M, Grigsby J, Kaye K et al. High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc 1992; 40: 1197-204.
16. Yao Y, Yao SL, Yao SS, Yao G, Lou W. Prevalence of vitamin B12 deficiency among geriatric outpatients. J Fam Pract 1992; 35: 524-8.
17. Van der Does FEE, De Neeling JND, Snoek FJ, Kostense PJ, Grootenhuis PA, Bouter LM et al. Symptoms and well-being in relation to glycemic control in type II diabetes. Diabetes Care 1996; 19: 204-10.
18. Savage DG, Lindenbaum J, Stabler SP, Allen RH. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 1994; 96: 239-46.
19. Ubbink JB, Vermaak WJH, Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 1991; 565: 441-6.
20. Bailey CJ. Biguanides and NIDDM. Diabetes Care 1992; 15: 755-72.
21. Lindenbaum J, Rosenberg IH, Wilson PWF, Stabler SP, Allen RH. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 1994; 60: 2-11.
22. Rothenberg SP, Quadros EV. Transcobalamin II and the membrane receptor for the transcobalamin II-cobalamin complex. Ballieres Clin Haematol 1995; 8: 499-514.
23. Lindenbaum J, Savage DG, Stabler SP, Allen RH. Diagnosis of cobalamin deficiency; II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol 1990; 34: 99-107.
24. Herbert V. Staging vitamin B-12 (cobalamin) status in vegetarians. Am J Clin Nutr 1994; 59 (Suppl. 5): 1213-22.
25. Malinow MR, Levenson J, Giral P, Nieto FJ, Razavian M, Segond P et al. Role of blood pressure, uric acid, and hemorheological parameters on plasma homocyst(e)ine concentration. Atherosclerosis 1995; 114: 175-83.
26. Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE et al. Total plasma homocysteine and cardiovascular risk profile. JAMA 1995; 274: 1526-33.
27. Gartler SM, Hornung SK, Motulsky AG. Effect of chronologic age on induction of cystathionine synthase, uroporphyrinogen I synthase, and glucose-6-phosphate dehydrogenase activities in lymphocytes. Proc Natl Acad Sci USA 1981; 78: 1916-9.
28. Mudd SH, Poole JR. Labile methyl balances for normal humans on various dietary regimens. Metabolism 1975; 24: 721-35.
29. Janssen MJFM, van den Berg M, Stehouwer CDA, Boers GHJ. Hyperhomocysteinaemia: a role in the accelerated atherogenesis of chronic renal failure? Neth J Med 1995; 46: 244-51.
30. Dastur DK, Quadros EV, Wadia NH, Desai MM, Bharucha EP. Effect of vegetarianism and smoking on vitamin B12, thiocyanate, and folate levels in the blood of normal subjects. Br Med J 1972; 821: 260-3.
31. Serfontein WJ, Ubbink JB, De Villiers LS, Becker PJ. Depressed plasma pyridoxal-5′-phosphate levels in tobacco-smoking men. Atherosclerosis 1986; 59: 341-6.
32. Mason JB, Miller JW. The effect of vitamins, B12, B6, and folate on blood homocysteine levels. Ann N Y Acad Sci 1992; 669: 197-204.
33. Selhub J, Miller JW. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 1992; 55: 131-8.
34. Ubbink JB, Vermaak WJH, Delport R, van der Merwe A, Becker PJ, Potgieter H. Effective homocysteine metabolism may protect South African blacks against coronary heart disease. Am J Clin Nutr 1987; 62: 802-8.
35. Herbert V. Recommended dietary intakes (RDI) of vitamin B-12 in humans. Am J Clin Nutr 1987; 45: 671-8.
36. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270: 2693-8.
37. Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Go RCP, Alvarez JO et al. Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 1994; 59: 940-8.